News Releases

News Releases

Share
Print
Share
Print
and/or
305 News Releases found

MSK Physician-Scientists Recognized with Top Honors by AACR, ASCO, and ASH Organizations

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and honors, given by the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the American Society of Hematology (ASH) organizations.

  • Monday, June 22, 2020

MSK’s Visible Ink Writing Program Presents “On Cancer and Coronavirus,” Performed by Stars of Broadway, Film and TV

On Thursday, June 18th at 6:00 p.m. E.T. with an encore at 9:00 p.m., MSK will stream a special performance highlighting poignant and humorous perspectives On Cancer and Coronavirus, featuring works from its writing program, Visible Ink.

  • Thursday, June 18, 2020

MSK KIDS Ranked One of the Best Children’s Hospitals Nationally in Pediatric Cancer Care by U.S. News & World Report

MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation. MSK Kids has been ranked by U.S. News & World Report for the past 12 years.

  • Tuesday, June 16, 2020

MSK Awards & Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

  • Monday, June 15, 2020

Memorial Sloan Kettering’s Charles L. Sawyers, MD, Named American Association for Cancer Research Academy President-Elect

The Fellows of the American Association for Cancer Research (AACR) have elected Charles L. Sawyers, MD, chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK), as their President-Elect for 2020–2021.

  • Friday, June 12, 2020

Memorial Sloan Kettering – Hackensack Meridian Health Partnership Announces Funding for Inaugural Immunology Research Collaboration Projects

The Memorial Sloan Kettering – Hackensack Meridian Health Partnership has formed an Immunology Research Collaboration to support innovative investigations into the power of the immune system to fight cancer.

  • Tuesday, June 9, 2020

A Letter to the MSK Community

Read a letter from Memorial Sloan Kettering's leadership team about our commitment to our community in response to acts of racism and discrimination.

  • Tuesday, June 2, 2020

ASCO 2020: Targeted Treatment Shows Promise in Non-Small Cell Lung Cancer

Researchers at MSK published updated data today in the New England Journal of Medicine from the ongoing, single-arm Phase II VISION study evaluating tepotinib as a single agent in patients with advanced non-small cell lung cancer (NSCLC) with MET exon 14 (METex14) skipping alterations.

  • Friday, May 29, 2020

MSK: Cancer Isn’t Sheltering in Place

As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now.

  • Tuesday, May 26, 2020

EGFR Targeting Improves Response to Previously Difficult to Treat Colorectal Cancers with KRAS Mutations

An international team of researchers led by Sandra Misale, research associate at the Sloan Kettering Institute, examined the effects of the experimental cancer drug, AMG510, which targets KRAS G12C cell lines, and found that the efficacy of such KRAS G12C inhibitors is lineage-specific. These findings provide a mechanistic understanding of the differences in response to KRAS G12C inhibitor in lung and colorectal cancers.

  • Tuesday, May 19, 2020